Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Calcium carbonate, Magnesium carbonate may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
for
Do not use this medicine after the expiry date which is stated on the carton and blister. The expiry date refers to the last day of that month.
e
250 mm
250 mm
Flamingo indigestion relief tablets
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
Adults and children 12 years and over: 2 tablets to be sucked or chewed, as required, preferably 1 hour after meals and before bedtime. For heartburn an extra 2 tablets may be taken between 6. Contents of the pack and other information these times. What Flamingo Indigestion Relief Peppermint Do not take more than 10 tablets a day. 680 mg / 80 mg chewable tablets contains Children under 12 years: Not recommended. The active substances are calcium carbonate 680mg If symptoms persist after 14 days consult your and magnesium carbonate 80mg in each chewable pharmacist or doctor. Prolonged use should be tablet. avoided. The other ingredients are: sucrose, potato starch, Tablets to be taken orally, sucked or chewed or pregelatinised starch, sodium saccharin, magnesium crushe completely and not to be swallowed whole. If you take more Flamingo indigestion relief tablets stearate, purified talc and peppermint flavor. Peppermint Flavor (ASV 030133) contains: flavourings than you should: natural, gum arabic/acacia gum, matlodextrin, sodium Drink plenty of water and consult your doctor or pharmacist. Symptoms of an overdose include nausea benzoate, butylated hydroxyanisole. and vomiting, tiredness, constipation and muscular What Flamingo indigestion relief tablets look weakness. like and contents of the pack If you have any questions on the use of this product, Flamingo indigestion relief tablets are white to off ask your doctor or pharmacist. white coloured, round tablet, plain on both sides. It may contain specks. Diameter- 16mm. 4. Possible side effects These tablets are available in plain aluminium foilPVC/PVDC clear film blister packs of 12, 24, 36, 48, Like all medicines, this medicine can cause side effects, although not everybody gets them. Side effects 72, 96 or 120 tablets. are unlikely at the recommended dose. If you Not all pack sizes may be marketed experience the following side effects stop treatment Marketing Authorisation Holder immediately and seek medical advice. Flamingo Pharma (UK) Ltd. Rarely allergic reactions to ingredients have been First Floor, Kirkland House, reported, e.g. rashes, itching, difficulty in breathing 11-15 Peterborough Road, and swelling of the face, mouth or throat and Harrow, Middlesex, anaphylactic shock (anaphylactic shock is a severe sudden allergic reaction, symptoms of which are low HA1 2AX, United Kingdom. blood pressure, shock, palpitations, difficulty in Manufacturer: breathing, bronchospasm, skin reactions, abdominal Flamingo Pharma (UK) Ltd. pain or cramps, vomiting and diarrhoea). The Bloc, 38 Springfield Way, Long term use of high doses can cause high blood Anlaby, Hull, HU 10 6RJ, levels of calcium and magnesium, especially in people United Kingdom with kidney conditions. Symptoms of this may include This leaflet was last revised in 02/2026. nausea, vomiting, upset stomach, constipation, diarrhoea, tiredness, muscular weakness, headache, To request a copy of this leaflet in Braille, large print kidney problems and impaired sense of taste. or audio please call free of charge: 0800 198 5000 In exceptional cases, long term use of high doses can (UK only). lead to milk alkali syndrome, which can cause high Please be ready to give the following information: blood levels of calcium. Product Name: Flamingo Indigestion Relief Reporting side effects Peppermint chewable tablets If you get any side effects, talk to your doctor, Reference Number: PL 43461/0127 pharmacist or nurse. This includes any possible side This is a service provided by the Royal National effects not listed in this leaflet. You can also report Institute of Blind People.
directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side affects you can help provide more information on the safety of this medicine.
Flamingo indigestion relief tablets Keep this medicine out of the sight and reach of children. Store below 25°C. Store in original package to protect from moisture.
GSL
MPLLCCM0760TBCOM FPLXXX401V01_A
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you.
medicinal product. May be harmful to the teeth. This medicine contains less than 1mmol sodium (23 mg) per tablet, that is to say it is essential 'sodium free'.
Package Leaflet: Information for the user
Flamingo Indigestion Relief Peppermint 680 mg / 80 mg chewable tablets calcium carbonate, magnesium carbonate
160 mm
160 mm
Flamingo Indigestion Relief Peppermint 680mg/ 80mg chewable tablets comes as tablet containing 680mg / 80mg. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Flamingo Indigestion Relief Peppermint 680mg/ 80mg chewable tablets is calcium carbonate, magnesium carbonate.
This leaflet reproduces the patient information leaflet approved for Flamingo Indigestion Relief Peppermint 680mg/ 80mg chewable tablets, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
For the relief of indigestion, heartburn, nervous indigestion, hyperacidity, flatulence, upset stomach, dyspepsia, biliousness, overindulgence in food and drink, indigestion during pregnancy.
Posology:
Adults and children 12 years and over:
Two tablets to be sucked or chewed as a single dose, preferably to be taken one hour after meals and before going to bed but also in between in case of heartburn or gastric pain. A maximum daily dose of 8 g calcium carbonate, corresponding to 10 tablets a day, must not be exceeded.
Children
Not recommended for children under 12 years of age.
As with all antacids, if symptoms persist despite 14 days of continuous therapy, diagnostic measures are strongly recommended in order to rule out a more serious disease.
Method of administration:
Tablets to be taken orally, sucked or chewed or crushed completely and not to be swallowed whole.
Flamingo Indigestion Relief Peppermint chewable tablets should not be administered to patients with:
• Hypersensitivity to any of the ingredients of the product
• Hypercalcaemia and/or conditions resulting in hypercalcaemia
• Nephrolithiasis due to calculi containing calcium deposits
• Severe renal insufficiency
• Hypophosphataemia
• Prolonged use should be avoided.
• The stated dose should not be exceeded. If, after 14 days of treatment, symptoms persist or only partly disappear the patient should consult a doctor.
• Caution should be exercised in patients with mild to moderate impairment of renal function (see section 4.3 – contraindication in severe renal insufficiency). If Flamingo Indigestion Relief Peppermint chewable tablets is used in such patients, plasma calcium, phosphate and magnesium levels should be regularly monitored.
• Long term uses at high doses can result in undesirable effects such as hypercalcaemia, hypermagnesaemia and milk-alkali syndrome, especially in patients with renal insufficiency.
• Flamingo Indigestion Relief Peppermint chewable tablets should not be used in patients with hypercalciuria (see also section 4.3). Prolonged use increases the risk of formation of renal calculi.
• This product should not be taken with large amounts of milk or dairy products.
This medicine contains sucrose. Patients with rare hereditary problems of fructose intolerance, glucose galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.
This medicine contains less than 1 mmol (23mg) sodium per tablet, that is to say essentially 'sodium-free'.
Changes in gastric acidity, such as that caused by the ingestion of antacids, can affect the rate and degree to which some concurrently administered medicines are absorbed.
• It has been shown that antacids which contain calcium or magnesium may form complexes with certain substances e.g. antibiotics (such as tetracyclines and quinolones), and cardiac glycosides (e.g. digoxin), bisphosphonates, dolutegravir, levothyroxine, and eltrombopag, resulting in decreased absorption. This should be borne in mind when concomitant administration is considered.
• Calcium salts reduce the absorption of fluorides and iron-containing products, and calcium salts and magnesium salts can hinder the absorption of phosphates.
• Thiazide diuretics reduce the urinary excretion of calcium. Due to an increased risk of hypercalcaemia, serum calcium should be regularly monitored during concomitant use of thiazide diuretics.
Therefore it is preferable to take the antacid separately from other drugs, allowing at least 4 hours before or after taking eltrombopag and a 1-2 hour interval for all other drugs.
Pregnancy and breast-feeding
No increased risk of congenital defects has been observed after the use of this Product during pregnancy and it can be used during pregnancy and lactation if taken as instructed but prolonged intake of high dosages should be avoided. Pregnant women should limit the use of these products to the maximum recommended daily doses (see section 4.2).
During pregnancy and lactation, it has to be taken into account that the tablets provide a substantial amount of calcium in addition to dietary calcium intake. For this reason, pregnant women should strictly limit their use of tablets to the maximum recommended daily dose and avoid concomitant, excessive intake of milk and dairy products. This warning is to prevent calcium overload which might result in milk alkali syndrome.
Fertility
There is no evidence on the effects of this product on fertility in males or females.
No effects on ability to drive and use machines have been observed.
The listed adverse drug reactions are based on spontaneous reports, thus an organisation according to CIOMS III categories of frequency is not possible.
Immune System Disorders:
Hypersensitivity reactions have very rarely been reported. Clinical symptoms may include rash, urticaria, pruritus, angioedema, difficulty in breathing and anaphylaxis.
Metabolism and Nutrition Disorders:
Especially in patients with impaired renal function, prolonged use of high doses can result in hypermagnesaemia or hypercalcaemia and alkalosis which may give rise to gastric symptoms and muscular weakness (see below).
Gastrointestinal Disorders:
Nausea, vomiting, stomach discomfort, constipation and diarrhoea may occur.
Musculoskeletal and Connective Tissue Disorders:
Muscular weakness may occur.
Undesirable effects occurring in the context of milk-alkali syndrome (see section 4.9)
Gastrointestinal Disorders:
Ageusia may occur in the context of milk-alkali syndrome.
General Disorders and Administration Site Conditions:
Calcinosis and asthenia may occur in the context of milk-alkali syndrome.
Nervous System Disorders:
Headache may occur in the context of milk-alkali syndrome.
Renal and Urinary Disorders:
Azotemia may occur in the context of milk-alkali syndrome.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme; website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Especially in patients with impaired renal function, prolonged use of high doses of calcium carbonate and magnesium carbonate can result in renal insufficiency, hypermagnesaemia, hypercalcaemia and alkalosis which may give rise to gastrointestinal symptoms (nausea, vomiting, constipation) and muscular weakness. In these cases, the intake of the product should be stopped and adequate fluid intake encouraged. In severe cases of over dosage (e.g. milk-alkali syndrome), a health care professional must be consulted because other measures of rehydration (e.g. infusions) might be necessary.
Medicines sold in Romania with the same active substance: Cunoscut în România ca
⚠ Not the same combination. This medicine contains Calcium carbonate, Magnesium carbonate. The products below do not contain exactly the same set of active substances — they are not direct substitutes.
⚠ Same active substance, but a different pharmaceutical form (for example a gel instead of a tablet). Not interchangeable — ask a pharmacist.
Some of these do not contain exactly the same active substances — check each one. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Romanian medicines in the UK →
Medicines sold in Poland with the same active substance: W Polsce znany jako
⚠ Not the same combination. This medicine contains Calcium carbonate, Magnesium carbonate. The products below do not contain exactly the same set of active substances — they are not direct substitutes.
Some of these do not contain exactly the same active substances — check each one. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →
Ask anything about Flamingo Indigestion Relief Peppermint 680mg/ 80mg chewable tablets. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.